Globe Life qualified for the five-stock high-ROE list by generating free cash flow above $1 billion and maintaining a return on equity that surpasses its industry peers. Additional filters included price/cash flow below the industry average and a Zacks Rank of 1 or 2, with Globe Life assigned a Rank #2.

Headquartered in McKinney, Texas, Globe Life operates insurance subsidiaries offering nonparticipating ordinary life products—traditional whole life and term life—alongside supplemental health coverage such as Medicare Supplement and critical illness plans. The company targets lower- to middle-income US households, emphasizing straightforward policy designs.

With a Zacks Rank #2 and strong efficiency metrics, Globe Life’s ability to reinvest cash at attractive returns underpins its valuation. Investors should evaluate mortality trends, regulatory developments and the performance of its investment portfolio to gauge potential impact on future earnings.